Jared Holz, Mizuho, joins ‘Fast Money’ to talk competition in the GLP-1 pill space between Novo Nordisk and Eli Lilly.
Source link
Trending
- Conversion is the ‘untold’ story of hospitality industry: Hilton
- 'Fast Money' traders talk market response to Fed rate cut decision
- The Fed’s interest rate cut doesn’t upended broad market themes, Jim Cramer says
- Pres. Trump wants a scapegoat for his base, says Fmr. Dallas Fed Pres. Fischer on feud with Powell
- Spirit CEO says airline will slash flights, could cut jobs
- Chart Master: Trim longs in Alibaba
- Mark Zuckerberg unveils $799 Meta Ray-Ban Display glasses
- Netskope prices IPO at $19, valuing company at $7.3 billion
Market delayed in reaction to Novo Nordisk and Eli Lilly' s GLP-1 pills, says Mizuho's Jared Holz
